{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:54:08Z","timestamp":1760144048248,"version":"build-2065373602"},"reference-count":50,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Moderate hypofractionated radiotherapy (MHRT) has emerged as the preferred treatment modality for localized prostate cancer based on randomized controlled studies regarding efficacy and toxicity using contemporary radiotherapy techniques. In the setting of MHRT, available data on dosimetric parameters and late rectal toxicity are limited. Aim: To present the effects of MHRT on late rectal toxicity while conducting an extensive dosimetric analysis in conjunction with rectoscopy results. Methods: This is a prospective study including patients with intermediate-risk prostate adenocarcinoma. All patients were treated with MHRT 44 Gy in 16 fractions to the seminal vesicles and to the prostate, followed by a sequential boost to the prostate alone of 16.5 Gy in 6 fractions delivered with three-dimensional conformal radiation therapy (3DCRT). Acute and late toxicity were assessed. Endoscopy was performed at baseline, every 3 months post-therapy for the first year, and every 6 months for the year after. The Vienna Rectoscopy Score (VRS) was used to assess rectal mucosal injury related to radiotherapy. Dosimetric analysis for the rectum, rectal wall, and its subsegments (upper, mid, and low 1\/3) was performed. Results: Between September 2015 and December 2019, 20 patients enrolled. Grade 1 late gastrointestinal toxicity occurred in 10% of the patients, whereas 5% had a grade \u22652. Twelve months post radiotherapy: 4 (20%) patients had VRS 1; 2 (10%) patients had VRS 2; 1(5%) patient had VRS 3. 24 months post radiotherapy, VRS 1 was observed in 4 patients (20%) and VRS 2 in 3 (15%) patients. The dosimetric analysis demonstrated noticeable variations between the rectum, rectal wall, and rectal wall subsegments. The dosimetric analysis of the rectum, rectal wall, and its mid and low segments with respect to rectoscopy findings showed that the higher dose endpoints V52.17Gy and V56.52Gy are associated with rectal mucosal injury. Conclusions: A thorough delineation of the rectal wall and its subsegments, together with the dosimetric analysis of these structures, may reduce late rectal toxicity. Dosimetric parameters such as V52.17Gy and V56.52Gy were identified to have a significant impact on rectal mucosal injury; additional dose endpoint validation and its relation to late GI toxicity is needed.<\/jats:p>","DOI":"10.3390\/cancers16061192","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T10:54:38Z","timestamp":1710759278000},"page":"1192","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive 3DCRT Hypofractionated Radiotherapy Schedule for Localized Prostate Adenocarcinoma in the Era of IMRT: Dosimetric and Endoscopic Analysis"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3576-5495","authenticated-orcid":false,"given":"Andromachi","family":"Kougioumtzopoulou","sequence":"first","affiliation":[{"name":"Radiotherapy Unit, 2nd Department of Radiology, ATTIKON University Hospital, Medical School, National & Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Syrigos","sequence":"additional","affiliation":[{"name":"Oncology Unit, 3rd Department of Internal Medicine, Medical School, National & Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Zygogianni","sequence":"additional","affiliation":[{"name":"1st Department of Radiology, Radiotherapy Unit, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Georgakopoulos","sequence":"additional","affiliation":[{"name":"1st Department of Radiology, Radiotherapy Unit, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalliopi","family":"Platoni","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, 2nd Department of Radiology, ATTIKON University Hospital, Medical School, National & Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Patatoukas","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, 2nd Department of Radiology, ATTIKON University Hospital, Medical School, National & Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6269-5360","authenticated-orcid":false,"given":"Kimon","family":"Tzannis","sequence":"additional","affiliation":[{"name":"Second Propaedeutic Department of Internal Medicine, \u2018Attikon\u2019 University Hospital, \u201cNational & Kapodistrian University of Athens, 12462 Chaidari, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5996-7262","authenticated-orcid":false,"given":"Aristotelis","family":"Bamias","sequence":"additional","affiliation":[{"name":"Second Propaedeutic Department of Internal Medicine, \u2018Attikon\u2019 University Hospital, \u201cNational & Kapodistrian University of Athens, 12462 Chaidari, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Kelekis","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, 2nd Department of Radiology, ATTIKON University Hospital, Medical School, National & Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Kouloulias","sequence":"additional","affiliation":[{"name":"Radiotherapy Unit, 2nd Department of Radiology, ATTIKON University Hospital, Medical School, National & Kapodistrian University of Athens, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"JCO1801097","DOI":"10.1200\/JCO.18.01097","article-title":"Hypofractionated Radiation Therapy for Local-ized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline","volume":"36","author":"Morgan","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_2","first-page":"943","article-title":"Evidence for efficacy without increased toxicity of hypofractionated radiotherapy for prostate carcinoma: Early results of a Phase III randomized trial","volume":"55","author":"Yeoh","year":"2003","journal-title":"Endocrine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijrobp.2016.12.034","article-title":"Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer","volume":"97","author":"Shaikh","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1200\/JCO.2018.77.9868","article-title":"Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer","volume":"36","author":"Hoffman","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1200\/JCO.2016.70.4189","article-title":"Moderate Hypofractionation in High-Risk, Organ-Confined Prostate Cancer: Final Results of a Phase III Randomized Trial","volume":"35","author":"Arcangeli","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"CHHiP Investigators Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijrobp.2019.09.007","article-title":"Hyprofractionated Versus Convention-ally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial","volume":"106","author":"Wortel","year":"2020","journal-title":"Int. J. Radiat. Oncolo-GyBiol. Phys."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","article-title":"Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients with Low-Risk Prostate Cancer","volume":"34","author":"Lee","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radio-therapy outcomes of 5,969 patients in seven international institutional datasets: \u03b1\/\u03b2 = 1.4 (0.9\u20132.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1756-9966-28-117","article-title":"Modeling of \u03b1\/\u03b2 for late rectal toxicity from a randomized phase II study: Conventional versus hypofractionated scheme for localized prostate cancer","volume":"28","author":"Marzi","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.ijrobp.2018.08.015","article-title":"A Systematic Post-QUANTEC Review of Tolerance Doses for Late Toxicity After Pros-tate Cancer Radiation Therapy","volume":"102","author":"Olsson","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ijrobp.2014.01.015","article-title":"Risk of Late Toxicity in Men Receiving Dose-Escalated Hypofrac-tionated Intensity Modulated Prostate Radiation Therapy: Results From a Randomized Trial","volume":"88","author":"Hoffman","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_16","first-page":"91","article-title":"Refinement & validation of rectal wall dose volume objectives for prostate hypofrac-tionation in 20 fractions","volume":"21","author":"Sanguineti","year":"2020","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00130404-200201000-00011","article-title":"Dose\/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: Absolute or relative rectal volume?","volume":"8","author":"Kupelian","year":"2002","journal-title":"Cancer J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ijrobp.2004.07.695","article-title":"Rectal bleeding after hypofractionated radiotherapy for prostate cancer: Correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding","volume":"60","author":"Akimoto","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.clon.2010.08.005","article-title":"Searching for optimal dose\u2013volume constraints to reduce rectal toxicity after hypofractionated radiotherapy for prostate cancer","volume":"22","author":"Faria","year":"2010","journal-title":"Clin. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1016\/j.ijrobp.2011.01.024","article-title":"Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy","volume":"81","author":"Vesprini","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Delobel, J.-B., Gnep, K., Ospina, J.D., Beckendorf, V., Chira, C., Zhu, J., Bossi, A., Messai, T., Acosta, O., and Castelli, J. (2017). Nomogram to predict rectal toxicity following prostate cancer radiotherapy. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179845"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.radonc.2019.02.014","article-title":"Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncolo-gy\/RTOG 0415","volume":"135","author":"Thor","year":"2019","journal-title":"Radiother. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0167-8140(99)00173-5","article-title":"Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma","volume":"54","author":"Wachter","year":"2000","journal-title":"Radiother. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2006.08.055","article-title":"Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC\/RTOG score for late rectal toxicity: Results of a prospective multicenter study of 166 patients","volume":"67","author":"Goldner","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.3109\/0284186X.2014.926029","article-title":"Patho-physiology of late anorectal dysfunction following external beam radiotherapy for prostate cancer","volume":"53","author":"Petersen","year":"2014","journal-title":"Acta Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.radonc.2012.05.010","article-title":"Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters","volume":"104","author":"Ippolito","year":"2012","journal-title":"Radiother. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/j.ijrobp.2011.12.046","article-title":"Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy","volume":"83","author":"Ippolito","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_28","first-page":"961","article-title":"Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer","volume":"31","author":"Ippolito","year":"2017","journal-title":"Vivo"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1016\/j.ijrobp.2009.03.078","article-title":"Radiation Dose\u2013Volume Effects in Radiation-Induced Rectal Injury","volume":"76","author":"Michalski","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_30","first-page":"59","article-title":"What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal study","volume":"14","author":"Alashkham","year":"2019","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ijrobp.2012.10.042","article-title":"Age and comorbid illness are associated with late rectal toxicity following dose-escalated radiation therapy for prostate cancer","volume":"85","author":"Hamstra","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13014-022-01998-4","article-title":"Patient-related risk factors for late rectal bleeding after hypofractionated radiotherapy for localized prostate cancer: A single-center retrospective study","volume":"17","author":"Kim","year":"2022","journal-title":"Radiat. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.21873\/invivo.12906","article-title":"Acute and Late Rectal Toxicity Following Hypofractionated Radiotherapy in Patients With Prostate Cancer: Results of a Prospective Study","volume":"36","author":"Kounadis","year":"2022","journal-title":"Vivo"},{"key":"ref_34","unstructured":"Rosenblatt, E., and Zubizarreta, E. (2017). Radiotherapy in Cancer Care: Facing the Global Challenge, International Atomic Energy Agency."},{"key":"ref_35","first-page":"827","article-title":"Global Radiotherapy: Current Status and Future Directions\u2014White Paper","volume":"7","author":"Gondhowiardjo","year":"2021","journal-title":"JCO Glob. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2012.11324.x","article-title":"An up-dated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011","volume":"111","author":"Eifler","year":"2013","journal-title":"BJU Int."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(01)01651-0","article-title":"A simple analytic derivation suggests that prostate cancer alpha\/beta ratio is low","volume":"51","author":"King","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.radonc.2006.05.012","article-title":"EORTC ra-diation oncology group Guidelines for primary radiotherapy of patients with prostate cancer","volume":"79","author":"Boehmer","year":"2006","journal-title":"Radiother. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative Anal-yses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific Issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e180039","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of Standard vs Dose-Escalated Radi-ation Therapy for Patients With Intermediate-Risk Prostate Cancer: The NRG Oncology RTOG 0126 Randomized Clinical Trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_42","unstructured":"(1995). LENT SOMA tables. Radiother. Oncol., 35, 17\u201360."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00066-004-1226-1","article-title":"A phase II randomized study of topical intrarectal administration of amifostine for the preven-tion of acute radiation-induced rectal toxicity","volume":"180","author":"Kouloulias","year":"2004","journal-title":"Strahlenther. Onkol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/1574887116666210509004418","article-title":"Moderate Hypofractionated Radiotherapy for Localized Prostate Cancer: The Triumph of Radiobiology","volume":"16","author":"Kougioumtzopoulou","year":"2021","journal-title":"Rev. Recent Clin. Trials"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00365528509089641","article-title":"Rectal wall thickness measured by ultrasound in chronic inflammatory diseases of the colon","volume":"20","author":"Rasmussen","year":"1985","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.ijrobp.2004.07.712","article-title":"Comparison of rectal dose\u2013wall histogram versus dose\u2013volume histogram for modeling the incidence of late rectal bleeding after radiotherapy","volume":"60","author":"Tucker","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1748-717X-1-34","article-title":"Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer","volume":"1","author":"Guckenberger","year":"2006","journal-title":"Radiat. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ijrobp.2006.09.034","article-title":"Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy","volume":"67","author":"Kristinsson","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/6\/1192\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:15:27Z","timestamp":1760105727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/6\/1192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["cancers16061192"],"URL":"https:\/\/doi.org\/10.3390\/cancers16061192","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2024,3,18]]}}}